00454nas a2200157   4500000000100000000000100001008004100002100001500043700001400058700001200072700001400084700002900098245015300127300000900280490000700289       2017                            d1 aS. Langham1 aA. Wright1 aH. Shaw1 aS. Bryson1 aS. O\textquoterightLeary00aBudget impact analysis of oral glycopyrronium bromide (Sialanar™) for the symptomatic treatment of severe sialorrhoea (Drooling) in the UK setting  aA7200 v20